Pebble Labs is a biotechnology company located in Los Alamos, at the New Mexico Consortium. Our focus is disease control and food security.
With a growing population and an increasing emergence of infectious diseases, there is a need for novel solutions. Pebble Labs' innovative patent-pending solutions are at the forefront of eliminating viruses in animals and plants, including those delivered by insects.
Led by our Chief Scientific Officer, Dr. Richard Sayre, a Senior Research Scientist at the Los Alamos National Laboratory and New Mexico Consortium, Pebble Labs has three main subsidiary companies.
- Little Fly Labs utilizes a proprietary mosquito treatment to block the expression and replication of vector-borne viruses, such as Zika, Dengue, Yellow Fever and West Nile Virus.
- Iron Leaf Biosciences focuses on plant protection by using endophytic bacteria to silence fungal and viral pathogen genes as well as insect pests.
- Imugenics provides solutions to the animal health industry, initially on the control of diseases that affect shrimps and high-value farmed fish but eventually extending in to poultry.
All three companies utilize Pebble Labs' platform delivery system which uses naturally occurring bacteria to produce double-stranded RNA to inhibit the expression of target genes. This RNA interference solution does not have any negative human, eco-system, or environmental impact associated with many competing control systems and can be applied cost-effectively in affected areas across the globe.
Nature video explaining how RNAi works.
Little Fly Labs
Little Fly Labs is developing innovative patent-pending solutions to control mosquito-borne diseases such as Zika, Dengue, Chikungunya, Yellow Fever and West Nile Virus. Our gene-silencing technology utilizes enteric bacteria to deliver species-specific and gene-specific double-stranded RNA intended to selectively incapacitate the disease-causing viruses in each mosquito.
Iron Leaf Biosciences
Iron Leaf Biosciences is developing a patented platform technology for the agriculture industry to combat pathogenic viruses and fungi, as well as damaging pests. The technology uses endophytic bacteria specific to each crop to deliver the double-stranded RNA intended to inactivate target genes.
Imugenics
Imugenics is developing non-antibiotic disease control protocols to administer and combat animal health problems in the aquaculture and poultry industries. Our technology reduces the likelihood of resistant mechanisms evolving (multiple-variant approach), providing robust antigen protection without the expensive cold chain requirements necessary with vaccines. Our solution will be incorporated into animal feeds providing a long and stable shelf life.